Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
OTC Markets OTCPK - Delayed Quote USD

Aibotics Inc. (AIBT)

Compare
0.0900
+0.0113
+(14.36%)
At close: 3:50:43 PM EST

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Benjamin Kaplan Chairman, Chief Executive and Financial Officer & President 288k -- 1972
Dr. Saphire Longmore MBBS Chief Medical Officer Of Caribbean Affairs -- -- --

Aibotics Inc.

100 SE 2nd Street
Suite 2000
Miami, FL 33131
United States
954 233 3511 https://www.mycotopiatherapies.com
Sector: 
Healthcare
Industry: 
Biotechnology

Description

Aibotics Inc. focuses on psychedelics for the treatment of mental health issues. It provides psychedelic therapies for the treatment of post-traumatic stress disorder, palliative care, depression, and anxiety. The company was formerly known as Mycotopia Therapies, Inc. and changed its name to Aibotics Inc. in February 2025 Aibotics Inc. is based in Miami, Florida. Aibotics Inc. is a subsidiary of EHAVE, Inc.

Corporate Governance

Aibotics Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers